Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
July 18, 2025 17:15 ET Â | Source: Iovance Biotherapeutics, Inc. SAN CARLOS,…
Cango Inc. Announces Results of Second Extraordinary General Meeting
HONG KONG, July 17, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango"…
Via announces confidential submission of draft registration statement related to proposed public offering
NEW YORK, July 16, 2025 /PRNewswire/ -- Via Transportation, Inc. today announced…
KEPSA and MindHYVE.ai Sign Strategic Agreement to Launch National-Scale AGI Workforce, SME, and Innovation Initiatives Across Kenya
NAIROBI, Kenya and NEWPORT BEACH, Calif., July 15, 2025 /PRNewswire/ -- The…
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue
ORLANDO, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded…
MindHYVE.ai Expands Agentic AI Infrastructure Across East Africa in Strategic Partnership Formalized at the AI for Good Global Summit in Geneva
GENEVA and NEWPORT BEACH, Calif., July 11, 2025 /PRNewswire/ -- MindHYVE.aiâ„¢, Inc.,…
Clarification on Leadership Announcement: Annette Slyman not to join Life Backup Plan as Chief Operating Officer
July 11, 2025 16:30 ET Â | Source: Life Backup Plan by Galacxia,…
Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
July 11, 2025 16:30 ET Â | Source: Ultragenyx Pharmaceutical Inc. Complete Response…
NKGen Biotech Administers First Dose of Troculeucel to Alzheimers Patient Who Continued to Decline Cognitively While on Prior Amyloid-Targeting Therapy
July 10, 2025 16:30 ET Â | Source: NKGen Biotech, Inc. SANTA ANA,…
Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 10, 2025 16:28 ET Â | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…